RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway

Preoperative chemoradiation combined with surgery has been of focus recently in order to improve prognosis in esophageal squamous cell carcinoma (ESCC) patients. Finding biological markers that may assist in predicting the therapeutic effect of chemoradiation may benefit the treatment effect. In this study, the role of RUNX3 in the formation of cisplatin resistance in ESCC was examined.

• Publication year

  2016

• Venue

  Thoracic Cancer

• Publication date

  2016-06-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1759-7714.12370PMID 27766776PMCID 5129150
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways.

  2015cited by this paper
• RUNX3 inhibits survivin expression and induces cell apoptosis in gastric cancer.

  2014cited by this paper
• Overexpression of RUNX3 inhibits malignant behaviour of Eca109 cells in vitro and vivo.

  2014cited by this paper
• Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy

  2014cited by this paper
• Low expression of claudin-4: an indicator of recurrence in esophageal squamous cell carcinoma after Ivor Lewis esophagectomy?

  2014cited by this paper
• RUNX family: Regulation and diversification of roles through interacting proteins

  2013cited by this paper
• Loss of runt‐related transcription factor 3 induces gemcitabine resistance in pancreatic cancer

  2013cited by this paper
• Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway.

  2013cited by this paper
• RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells

  2012cited by this paper
• Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell.

  2012cited by this paper
• Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.

  2011cited by this paper
• Phosphatidylinositol 3-Kinase-C2β Inhibits Cisplatin-Mediated Apoptosis via the Akt Pathway in Oesophageal Squamous Cell Carcinoma

  2011cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• RUNX3 Inhibits Cell Proliferation and Induces Apoptosis by TGF-β-Dependent and -Independent Mechanisms in Human Colon Carcinoma Cells

  2009cited by this paper
• Molecular pathology of RUNX3 in human carcinogenesis.

  2009cited by this paper
• RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.

  2008cited by this paper
• Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

  2008cited by this paper
• The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.

  2008cited by this paper
• Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.

  2007cited by this paper
• Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis

  2007cited by this paper
• Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy in patients with oesophageal cancer

  2007cited by this paper
• Low Expression of Bax Predicts Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Treated with Definitive Chemoradiotherapy

  2007cited by this paper
• Recurrence Pattern of Squamous Cell Carcinoma in the Middle Thoracic Esophagus after Modified Ivor-Lewis Esophagectomy

  2007cited by this paper
• Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography.

  2007cited by this paper
• Esophageal Cancer: Adjuvant Therapy

  2007cited by this paper
• Long-term Outcomes Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer

  2007cited by this paper
• Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities.

  2007cited by this paper
• Prognostic Factors After Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

  2007cited by this paper
• Expression of p53 and p21 and the clinical response for hyperthermochemoradiotherapy in patients with squamous cell carcinoma of the esophagus.

  2007cited by this paper
• 3'-deoxy-3'-(18)F-fluorothymidine (FLT) positron emission tomography for early prediction of response to chemoradiotherapy--a clinical application model of esophageal cancer.

  2007cited by this paper
• Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl‐2, MDR‐1 and MRP‐1

  2005cited by this paper
• RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.

  2004cited by this paper
• RUNX transcription factors as key targets of TGF-beta superfamily signaling.

  2003cited by this paper
• RUNX transcription factors as key targets of TGF-β superfamily signaling

  2003cited by this paper

• TRIM21 knockdown suppresses ESCC progression and induces autophagy-mediated apoptosis via AKT/mTOR signaling pathway.

  2025cites this paper
• Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning

  2025cites this paper
• MicroRNA-130a-3p regulates osimertinib resistance by targeting runt-related transcription factor 3 in lung adenocarcinoma

  2024cites this paper
• Silencing of lncRNA NEAT1 inhibits esophageal squamous cell carcinoma proliferation, migration, and invasion via regulation of the miR-1299/MMP2 axis

  2021cites this paper
• A nanomicelle with miR-34a and doxorubicin reverses the drug resistance of cisplatin in esophageal carcinoma cells by inhibiting SIRT1 signal pathway

  2020cites this paper
• RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial-mesenchymal transition through TGF-β/Smad signaling

  2020cites this paper
• Long noncoding RNA SNHG12 induces proliferation, migration, epithelial–mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post‐transcriptional regulation of BMI1 and CTNNB1

  2020cites this paper
• Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway

  2019cites this paper
• Preliminary screening of chemotherapy-resistant genes in esophageal cancer and its clinical significance

  2019cites this paper
• Long non-coding RNA FTH1P3 regulated metastasis and invasion of esophageal squamous cell carcinoma through SP1/NF-kB pathway.

  2018cites this paper
• Interplay between the NF‑κB and hedgehog signaling pathways predicts prognosis in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy.

  2018cites this paper
• MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway.

  2017cites this paper
• LncRNA NEAT1 Regulates Cell Viability and Invasion in Esophageal Squamous Cell Carcinoma through the miR-129/CTBP2 Axis

  2017cites this paper
• Effects of RUNX 3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells

  2017cites this paper
• Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells.

  2017cites this paper
• MCM 7 amplification and overexpression promote cell proliferation , colony formation and migration in esophageal squamous cell carcinoma by activating the AKT 1 / mTOR signaling pathway

  year unknowncites this paper